Related Experiment Video

Updated: Jun 28, 2026

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
14:56

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants

Published on: February 8, 2012

New evaluation of the Toxoplasma ELITe MGB assay on the ELITe Ingenius™ platform (ELITechGroup)

Marie-Pierre Brenier-Pinchart1,2,3, Cécile Garnaud4,5, Gaelle Dewaele4

  • 1Service de Parasitologie-Mycologie, CHU Grenoble Alpes, Grenoble, France. mpbrenierpinchart@chu-grenoble.fr.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|September 18, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
09:49

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Related Experiment Videos

Last Updated: Jun 28, 2026

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
14:56

A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants

Published on: February 8, 2012

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
11:21

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity

Published on: March 12, 2015

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
09:49

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

Articles linked to this work by shared authors, journal, and citation graph.

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Seasonal variations in mold identification in medical microbiology laboratories using MSI-2 application, France (2020-2024).

Medical mycology·2026

Immunological fitness of echinocandin-resistant Nakaseomyces glabratus (former Candida glabrata): The impact on the management of candidemia.

Virulence·2026

Assessing laboratory capacity for diagnosis of fungal infections in France: A multicentre survey within the SINFONI network.

Medical mycology·2026

Diagnosis and treatment of congenital toxoplasmosis: an updated overview.

Expert review of anti-infective therapy·2026

Clinical characteristics and treatments of imported loiasis patients with microfilaraemia diagnosed in France, 2000-2022.

Travel medicine and infectious disease·2026

First evaluation of ThermoSscientific Brilliance Candida 2 Agar for presumptive Candidozyma auris identification and comparison with CHROMagar Candida Plus.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Therapeutic drug monitoring of high-dosage intravenous flucloxacillin and mortality in patients with Staphylococcus aureus bacteremia: a retrospective cohort study using inverse probability weighting.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

A multi-site observational study of rationality assessment for carbapenem use in China: carbapenem stewardship opportunities.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Microbiological profile and 28-day mortality prediction model for bloodstream infection in patients with acute-on-chronic liver failure.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Clinical performance of the Abbott RealTime Mycobacterium tuberculosis (MTB) PCR on bronchoscopic specimens for diagnosing pulmonary tuberculosis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Early bedside risk stratification using Charlson comorbidity index and NEWS2 in adults hospitalized with respiratory syncytial virus infection: a multicentre cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

The role of pathology laboratories in integrating genetic testing into Australian primary care: an implementation science perspective.

European journal of human genetics : EJHG·2026

Integration of lipoprotein(a) testing into inpatient cardiology-lipid clinic pathway: A 2-year review of LILAC heart initiative using RE-AIM framework.

Journal of clinical lipidology·2026

Uptake and feasibility of task-shifting of Xpert MTB/RIF Ultra testing from laboratory technicians to nurses to increase access and reduce time to results: a multicountry mixed method research.

BMJ global health·2026

Molecular Rejection Signatures in Pancreas Transplant Biopsies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

GENERATIVE AI FOR HIRSCHSPRUNG DISEASE: CAN SYNTHETIC FLUORESCENCE CONFOCAL MICROSCOPY IMAGES ENHANCE INTRAOPERATIVE DETECTION OF GANGLIONIC BOWEL?

Journal of pediatric surgery·2026

Reporting the decision-attributable failure rate alongside the pooled failure rate in rule-out diagnostic-management studies.

Journal of clinical epidemiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us